The Current Ratio as of December 2025 (TTM) for Nykode Therapeutics AS (NYKD.OL) is 15.21

According to Nykode Therapeutics AS’s latest financial reports and current stock price. The company's current Current Ratio is 15.21. This represents a change of 14.90% compared to the average of 13.24 of the last 4 quarters.

Nykode Therapeutics AS (NYKD.OL) Historical Current Ratio (quarterly & annually)

How has NYKD.OL Current Ratio performed in the past?

The mean historical Current Ratio of Nykode Therapeutics AS over the last ten years is 11.33. The current 15.21 Current Ratio has changed 13.33% with respect to the historical average. Over the past ten years (40 quarters), NYKD.OL's Current Ratio was at its highest in in the June 2017 quarter at 40.84. The Current Ratio was at its lowest in in the March 2015 quarter at 0.

Nykode Therapeutics AS (NYKD.OL) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Nykode Therapeutics AS Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Nykode Therapeutics AS (NYKD.OL) Average Current Ratio

How has NYKD.OL Current Ratio performed in the past?

The current Current Ratio of Nykode Therapeutics AS (NYKD.OL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Nykode Therapeutics AS (NYKD.OL) Current Ratio vs. Peers

How is NYKD.OL’s Current Ratio compared to its peers?

Nykode Therapeutics AS’s Current Ratio is greater than Hofseth BioCare ASA (0.96), greater than Lytix Biopharma AS (5.85), greater than Gentian Diagnostics ASA (5.47), greater than BerGenBio ASA (4.39), greater than Navamedic ASA (1.30), greater than Arctic Bioscience AS (0.83), greater than PCI Biotech Holding ASA (2.94), greater than Thor Medical ASA (8.87), less than ArcticZymes Technologies ASA (15.90), greater than ContextVision AB (publ) (4.12),

Build a custom stock screener for Nykode Therapeutics AS (NYKD.OL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nykode Therapeutics AS using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Nykode Therapeutics AS (NYKD.OL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Nykode Therapeutics AS or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.